Abstract
The toxicology of the food preservatives butylhydroxyanisole (BHA) and butylhydroxytoluene (BHT) as well as the naturally occurring vitamin E (α-tocopherol) is described. In high dosages all three compounds induce in animals impairment of blood clotting, which can be explained by an antagonism with vitamin K. Specific toxic effects to the lung have only been observed with BHT. The other described toxic effects of BHA and BHT are less characteristic and often occur only after high dosage and long-term treatment. However, BHA induces in animals tumours of the forestomach, which are dose dependent, whereas BHT induces liver tumours in long-term experiments. Because there is no indication of genotoxicity of BHA and BHT, all published findings agree with the fact that BHA and BHT are tumour promoters. In contrast to BHA and BHT, vitamin E is not carcinogenic. On the other hand, all three antioxidants have also anticarcinogenic properties. The intake of the necessary high doses as for these effects are, however, contraindicated with BHA and BHT because of their carcinogenic effects. The present overview concludes that the concentrations of BHA and BHT nowadays used in food, drugs and cosmetics are probably harmless. In addition, vitamin E can also be used in higher doses without the occurrence of adverse effects.
Zusammenfassung
Die Toxikologie der Lebensmittelzusatzstoffe Butylhydroxyanisol (BHA) und Butylhydroxytoluol (BHT) sowie des natürlich vorkommenden Vitamin E (α-Tocopherol) wird beschrieben. Alle drei Verbindungen verursachen im Tierversuch bei hoher Dosierung Störungen der Blutgerinnung, die mit einem Vitamin-K-Antagonismus erklärbar sind. Spezifische toxische Effekte auf die Lunge sind nur mit BHT beobachtet worden. Die sonst beschriebenen toxischen Wirkungen von BHA und BHT sind wenig charakteristisch und treten zum Teil erst bei sehr hoher Dosierung und bei Langzeitbehandlung auf. BHA induziert jedoch bei Tieren dosisabhängig Tumoren des Vormagens, während BHT im Langzeitversuch Lebertumoren erzeugt. Da es keinen Hinweis auf eine Gentoxizität von BHA und BHT gibt, sprechen alle bisherigen Befunde dafür, daß BHA und BHT Tumorpromotoren sind. Im Gegensatz zu BHA und BHT ist Vitamin E nicht cancerogen. Andererseits besitzen alle drei Antioxidantien auch anticancerogene Eigenschaften. Die Aufnahme hoher Dosen, wie sie für diese Effekte notwendig sind, verbietet sich jedoch bei BHA und BHT wegen ihrer cancerogenen Wirkungen. Die vorliegende Übersicht kommt zu dem Schluß, daß die in Lebensmitteln, Arzneimitteln und Cosmetica zur Zeit verwendeten Konzentrationen von BHA und BHT wahrscheinlich unbedenklich sind. Vitamin E kann darüber hinaus auch in höheren Dosen eingenommen werden, ohne daß unerwünschte Wirkungen auftreten.
Similar content being viewed by others
Literatur
Kirkpatrick DC, Lauer BH (1986) Food Chem Toxicol 24:1035–1037
National Academy of Sciences (1979) 1977 Survey of industry on the use of food additives, 296. NAS, Washington, D.C., Part 2, p 963; Part 3, p 127
Scientific Committee for Food of the Commission of the European Communities (1987) Report on antioxidants, p 6
Conacher HBS, Iverson F, Lau BJ, Page BD (1986) Food Chem Toxicol 24:1159–1162
Kahl R (1984) Toxicology 33:185–228
Van der Heijden CA, Janssen PJCM, Strik JJTWA (1986) Food Chem Toxicol 24:1067–1070
Suzuki H, Nakao T, Hiraga K (1979) Toxicol Appl Pharmacol 50:261–266
Takahashi O, Hiraga K (1978a) Toxicol Appl Pharmacol 43:399–406
Takahashi O, Hayashida S, Hiraga K (1980) Food Cosmet Toxicol 18:229–235
Takahashi O (1987) Food Chem Toxicol 25:219–224
Suzuki H, Nakao T, Hiraga K (1983) Toxicol Appl Pharmacol 67:152–155
Takahashi O, Hiraga K (1984) Food Chem Toxicol 22:97–103
Takahashi O (1988) Arch Toxicol 62:325–327
Takahashi O, Hiraga K (1978b) Food Cosmet Toxicol 16:475–477
Takahashi O, Sakamoto Y, Hiraga K (1985) Toxicol Lett 27:15–25
Wheldon GH, Bhatt A, Keller P, Hummler H (1983) Int J Vit Res 53:287–296
Abdo KM, Rao G, Montgomery CA, Dinowitz M, Kanagalingam K (1986) Food Chem Toxicol 24:1043–1050
Kappus H, Diplock AT (1992) Free Rad Biol Med 13:55–74
Marino AA, Mitchell JT (1972) Proc Soc Exp Biol Med 140:122–125
Adamson IYR, Bowden DH, Cote MG, Witschi HP (1977) Lab Invest 36:26
Smith LJ (1984) Am Rev Respir Dis 130:895–904
Hirai KI, Witschi HP, Cote MG (1978) Exp Molec Pathol 27:285–308
Kawano S, Nakao T, Hiraya K (1981) Toxicol Appl Pharmacol 61:475–479
Mizutani T, Nomura H, Yamamoto K, Tajima K (1984) Toxicol Lett 23:327–331
Tajima K, Yamamoto K, Mizutani T (1985) Biochem Pharmacol 34:2109–2114
Yamamoto K, Tajima K, Mizutani T (1980) Toxicol Lett 6:173–175
Malkinson AM, Thaete LG, Blumenthal EJ, Thompson JA (1989) Toxicol Appl Pharmacol 101:196–204
Kahl R, Weimann A, Weinke S, Hildebrandt AG (1987) Arch Toxicol 60:158–162
Omaye ST, Reddy KA, Cross CE (1977) J Toxicol Environ Health 3:829–836
Haschek WM, Witschi HP (1979) Toxicol Appl Pharmacol 51:475–487
Witschi H, Malkinson AM, Thompson JA (1989) Pharmacol Therapeut 42:89–114
Allen JR, Engblom JF (1977) Food Cosmet Toxicol 10:769–779
Yang NY, Desai ID (1977) J Nutrition 107:1410–1417
Hansen EV, Meyer O, Olsen P (1982) Toxicology 23:79–83
National Institutes of Health (NIH) (1979) DHEW Publication No. 79-1706
Nakagawa Y, Tayama K, Nakao T, Hiraga K (1984) Biochem Pharmacol 33:2669–2674
Powell CJ, Connelly JC, Jones SM, Grasso P, Bridges JW (1986) Food Chem Toxicol 24:1131–1143
Clapp NK, Tyndall RL, Cumming RB (1973) Food Cosmet Toxicol 11:847–849
Denz FA, Llaurado JG (1957) Br J Exp Pathol 38:515–524
Ford SM, Hook JB, Bond JT (1980) Food Cosmet Toxicol 18:15–20
Ford SM, Hook JB, Bond JT (1980) Food Cosmet Toxicol 18:21–26
Della Corte L, Sgaragli GP (1984) Pharmacol Res Commun 16:1041–1047
Sgaragli GP, Valoti M, Palmi M, Mantovani P (1989) Pharmacol Res 21:649–650
Valoti M, Delia Corte L, Tipton KF, Sgaragli G (1988) Biochem J 250:501–507
Stewart RM, Weir EK, Mongomery MR, Niewoehner DE (1981) Respir Physiol 45:333–342
Leslie SW, Gad SC, Acosta D (1978) Toxicology 10:281–289
Gad SC, Leslie SW, Acosta D (1979) Toxicol Appl Pharmacol 49:45–52
Sondergaard D, Olsen P (1982) Toxicol Lett 10:239–244
Hirose M, Shibata M, Hagiwara A, Imaida K, Ito N (1981) Food Cosmet Toxicol 19:147–151
Takahashi O, Hiraga K (1981) Toxicology 22:161–170
Marx W, Marx L, Meserve ER, Shimoda F, Deuel HJ (1947) Arch Pathol 47:440–445
Mellette SJ, Leone LA (1960) Fed Proc Fed Am Soc Exp Biol 19:1045–1049
Brown ND, Johnson AR, O'Halloran MW (1959) Aust J Exp Biol 37:533–548
Stokes JD, Scudder CL (1974) Dev Psychobiol 7:343–350
Vorhees CV, Butcher RE, Brunner RL, Wootten V, Sobotka TJ (1981) Neurobehav Toxicol Teratol 3:321–329
Vorhees CV, Butcher RE, Brunner RL, Wootten V, Sobotka TJ (1981) Food Cosmet Toxicol 19:153–162
Clegg DJ (1965) Food Cosmet Toxicol 3:387–403
Allen JR (1976) Arch Environ Health 31:47–50
Martin MM, Hurley LS (1977) Am J Clin Nutr 30:1629–1637
Hook EB, Healy KM, Niles AM, Skalko RC (1974) Lancet I:809
Krasavage WJ, Terhaar CJ (1977) J Agric Food Chem 25:273–278
Ito N, Hagiwara A, Shibata M, Ogiso T, Fukushima S (1982) Gann 73:332–334
Ito N, Fukushima S, Hagiwara A, Shibata M, Ogiso T (1983) J Nat Cancer Inst 70:343–352
Masui T, Hirose M, Imaida K, Fukushima S, Tamano S, Ito N (1986) Jpn J Cancer Res 77:1083–1090
Sato H, Takahashi M, Furukawa F, Miyakawa Y, Hasegawa R, Toyoda K, Hayashi Y (1987) Cancer Lett 38:49–56
Arno H, Kubota H, Lu J, Matsuyama M (1990) Carcinogenesis 11:151–154
Park EH, Chang HH, Cha YN (1990) Jpn J Cancer Res 81:738–741
Iverson F, Truelove J, Nera E, Wong J, Lok E, Clayson DB (1985) Cancer Lett 26:43–50
Altmann HJ, Grunow W, Mohr U, Richter-Reichhelm HB, Wester PW (1986) Food Chem Toxicol 24:1183–1188
Clayson DB, Iverson F, Nera E, Lok E, Rogers C, Rodrigues C, Page D, Karpinski K (1986) Food Chem Toxicol 24:1171–1182
Newberne PM, Charnley G, Adams K, Cantor M, Roth D, Supharkarn V (1986) Food Chem Toxicol 24:1111–1119
Hirose M, Masuda A, Kurata Y, Ikawa E, Mera Y, Ito N (1986) JNCI 76:143–147
Ito N, Hirose M (1987) Gann 78:1011–1026
Ikeda GJ, Stewart JE, Sapienza PP, Peggins JO III, Michel TC, Olivito V, Alam HZ, O'Donnell WM Jr (1986) Food Chem Toxicol 24:1201–1221
Tobe M, Furuya T, Kawasaki Y, Naito K, Sekita K, Matsumoto K, Ochiai T, Usui A (1986) Food Chem Toxicol 24:1223–1228
Würtzen G, Olsen P (1986) Food Chem Toxicol 24:1229–1233
World Health Organisation (1989) The 33rd Meeting of the Joint FAO/WHO Expert Committee of Food Additives, Geneva 21–30 March 1989. Cambridge University Press, Cambridge NY
Williams GM (1986) Food Chem Toxicol 24:1163–1166
Hageman GJ, Verhagen H, Kleinjans JC (1988) Mutat Res 208:207–211
Phillips BJ, Carroll PA, Tee AC, Anderson D (1989) Mutat Res 214:105–114
Matsuoka A, Matsui M, Miyata N, Sofuni T, Ishidate M Jr (1990) Mutat Res 24:125–132
Kahl R, Weinke S, Kappus H (1989) Toxicology 59:179–194
Sakai A, Miyata A, Takahashi A (1990) Carcinogenesis 11:1985–1988
Troll W, Wiesner R (1985) Annu Rev Pharmacol Toxicol 25:509–528
Kensler TW, Taffe BG (1986) Free Rad Biol Med 2:347–387
Altmann HJ, Wester PW, Matthiaschk G, Grunow W, Heijden CA van der (1985) Food Chem Toxicol 23:723–731
Mera EA, Iverson F, Lok E, Armstrong CL, Karpinski K, Clayson DB (1988) Toxicology 53:251–268
Masui T, Asamoto M, Hirose M, Fukushima S, Ito N (1987) Cancer Res 47:5171–5174
Hirose M, Masuda A, Hasegawa R, Wada S, Ito N (1990) Carcinogenesis 11:239–244
Ito N, Hirose M, Fukushima S, Tsuda H, Shirai T, Tatematsu M (1986) Food Chem Toxicol 24:1071–1082
Olsen P, Meyer O, Bille N, Würtzen G (1986) Food Chem Toxicol 24:1–12
Inai K, Kobuke T, Nambu S, Takemoto T, Kou E, Nishina H, Fujihara M, Yonehara S, Suehiro S, Tsuya T, Horiuchi K, Tokuoka S (1988) Jpn J Cancer Res 79:49–58
Clapp NK, Tyndall RL, Cumming RB, Otten JA (1974) Food Chem Toxicol 12:367–371
Food and Drug Administration, USA (1977) Butylated hydroxytoluene. Use restrictions in: Fed Regist 42:27–603
Shirai T, Hagiwara A, Kurata Y, Shibata M, Fukushima S, Ito N (1982) Food Cosmet Toxicol 20:861–865
Sheu CW, Cain KT, Rushbrook CJ, Jorgenson TA, Generoso WM (1986) Environ Mutagen 8:357–367
Bruce WR, Heddle JA (1979) Can J Genet Cytol 21:319–334
McGregor DB, Brown A, Cattanach P, Edwards I, McBride D, Caspary WJ (1988) Environ Mol Mutagen 11:91–118
Taffe BG, Kensler TW (1988) Res Commun Chem Pathol Pharmacol 61:291–303
Thompson JA, Schullek KM, Fernandez CA, Malkinson AM (1989) Carcinogenesis 10:773–775
Trosko JE, Yotti LP, Warren ST, Tsushimoto G, Chang C (1982) Carcinogenesis 7:565–585
Masui T, Fukushima S, Katoh F, Yamasaki H, Ito N (1987) Carcinogenesis 9:1143–1146
Kitchin KT, Brown JL (1987) Food Chem Toxicol 25:603–607
Potenberg J, Schiffmann D, Kahl R, Hildebrandt AG, Henschler D (1986) Cancer Lett 33:189–198
Djurhuus R, Lillehaug JR (1982) Bull Environ Contam Toxicol 29:115–120
Fukushima S, Sakata T, Tagawa Y, Shibata MA, Hirose M, Ito N (1987a) Cancer Res 47:2113–2115
Shirai T, Fukushima S, Ohshima M, Masuda A, Ito N (1984) JNCI 72:1189–1198
Imaida K, Fukushima S, Shirai T, Masui T, Ogiso T, Ito N (1983) Gann 75:769–775
Shirai T, Ikawa E, Hirose M, Thamayit W, Ito N (1985) Carcinogenesis 6:637–639
Lindenschmidt RC, Tryka AF, Witschi H (1987) Fundam Appl Toxicol 8:474–481
Weisburger EK, Evarts RP, Wenk ML (1977) Food Cosmet Toxicol 15:139–142
Lindenschmidt RC, Tryka AF, Goad ME, Witschi HP (1986) Toxicology 38:151–160
Funato T, Yokota J, Sakamoto H, Kameya T, Fukushima S, Ito N, Terada M, Sugimura T (1987) Jpn J Cancer Res (Gann) 78:689–694
Imaida K, Fukushima S, Inoue K, Masui T, Hirose M, Ito N (1988) Cancer Lett 43:167–172
Peraino C, Fry RJM, Staffeldt E, Christopher JP (1977) Food Cosmet Toxicol 15:93–96
Maeura Y, Williams GM (1986) Food Chem Toxicol 22:191–198
Thornton M, Moore MA, Ito N (1989) Carcinogenesis 10:407–410
Sakata T, Shirai T, Fukushima S, Hasegawa R, Ito N (1984) Gann 75:950–956
Fukushima S, Ogiso T, Kurata Y, Hirose M, Ito N (1987b) Cancer Lett 34:83–90
Maeura Y, Weisburger JH, Williams GM (1984) Cancer Res 44:1604–1610
Imaida K, Fukushima S, Shirai T, Ohtani M, Nakanishi K, Ito N (1983) Carcinogenesis 4:895–899
Thamavit W, Fukushima S, Kurata Y, Asamoto M, Ito N (1989) Cancer Lett 45:93–101
Chung FL, Wang M, Carmella SG, Hecht SS (1986) Cancer Res 46:165–168
Witschi HP, Morse CC (1983) JNCI 71:859–865
Witschi HP, Lock S (1978) Toxicology 9:137–146
Witschi HP, Kehrer JP (1982) J Am Coll Toxicol 1:171–184
Wattenberg LW (1985) Cancer Res 45:1–8
Kahl R (1986) J Environ Sci Health C4:47–92
McCormick DL, Major N, Moon RC (1984) Cancer Res 44:2858–2863
Cohen LA, Polansky M, Furuya K, Reddy M, Berke B, Weisburger JH (1984) JNCI 72:165–173
Toth B, Patil K (1983) JNCI 70:1107–1111
Cook MG, McNamara P (1980) Cancer Res 40:1329–1331
Roed-Petersen J, Hjorth N (1976) Br J Dermatol 94:233–241
Bentley-Phillips B, Bayles MAH (1974) Arch Dermatol 109:216–217
Shlian DM, Goldstone J (1986) N Engl J Med 314:648–649
Grogan WA (1986) West J Med 145:245–246
Fisherman EW, Cohen G (1973) Ann Allerg 31:126–133
Cloninger P, Novey HS (1974) Ann Allerg 32:131–133
Verhagen H, Maas LM, Beckers RHG, Thijssen HHW, Hoor F ten, Henderson PT, Kleinjans JCS (1989) Hum Toxicol: 451–459
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahl, R., Kappus, H. Toxikologie der synthetischen Antioxidantien BHA und BHT im Vergleich mit dem natürlichen Antioxidans Vitamin E. Z Lebensm Unters Forch 196, 329–338 (1993). https://doi.org/10.1007/BF01197931
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01197931